Researchers at the University of Alabama at Birmingham are working to better understand ALS and find new ways to slow or stop the disease.

A Lawrence Livermore National Laboratory (LLNL)-led team of scientists and computational engineers using one of the largest electronic health record datasets ever assembled for ALS has identified ...

To our knowledge, this analysis is the largest EHR-based study for identifying drug repurposing candidates for ALS. We identified several drugs that warrant further assessment as therapeutic options ...

The demand for advanced Neurodegenerative Disease Devices is being significantly driven by the growing burden of progressive neurological disorders across developed healthcare economies. Rapid ...

Positive data from EXPERTS-ALS could accelerate RT1999 towards a registration trial; RT1999 to be presented as a poster ...

People with an ALS diagnosis will experience muscle weakness as their nerve cells deteriorate over time. The cause is still ...

Eric Dane died at the age of 53 on February 19. The American actor, who was most popular for portraying Dr Mark Sloan, aka McSteamy, in the hit medical drama Grey’s Anatomy, passed away following a ...

In February 2026, XellSmart Pharmaceutical Co., Ltd. (XellSmart) announced that it had secured its fourth US FDA and China NMPA clearance for Phase I/II registrational clinical trial entry with its ...

Palliative care physician, Dr. Mapa, and ALS researcher, Dr. Leitner, comment on the life and death for patients with ALS as well as future researchers.

Patrick Dempsey speaks emotionally about Eric Dane’s ALS battle and death, remembering his “Grey’s Anatomy” costar as deeply missed.

This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo in ALS ...

Interim data support including an open-label extended dosing period to ANQUR protocol; approval received in Canada and under regulatory review in other regions; preparations underway to advance ...